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Abstract
Background—The Strengthening Laboratory Management Toward Accreditation (SLMTA) 
programme is a large-scale effort to improve the quality of laboratories in resource-limited 
countries.
Objectives—This study sought to evaluate the first four years (2010–2013) of SLMTA 
implementation.
Methods—Country-level data were submitted by SLMTA programme leads and compiled 
globally. Performance was measured before (baseline) and after (exit) SLMTA implementation 
using an audit checklist which results in a percentage score and a rating of zero to five stars. Some 
laboratories continued to monitor performance in post-exit surveillance audits. We evaluated score 
improvements using two-tailed t-tests for equal variances and estimated the number of tests 
performed by SLMTA laboratories based on star level.
Results—SLMTA was implemented in 617 laboratories in 47 countries in Africa, the Caribbean, 
Latin America and Southeast Asia. At the baseline audit, the laboratories scored an average of 
39% on the checklist and 84% of them were rated below one star. As of December 2013, 302 
laboratories had completed the SLMTA programme; mean checklist scores increased from 39% at 
baseline to 64% at exit (p < 0.001) over an average 16-month programme duration. Ninety-two 
laboratories conducted a surveillance audit at a median of 11 months after their exit audit; 62% 
further increased their performance. Six SLMTA laboratories have achieved accreditation status. 
In total, the 617 SLMTA laboratories conduct an estimated 111 million tests annually. Only 16% 
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of these tests were conducted by laboratories with at least one star at baseline, which increased to 
68% of tests after SLMTA training. Thus, approximately 23 million tests are conducted annually 
by laboratories previously at zero stars that now have one to five stars; this number is projected to 
increase to 58 million when currently-enrolled laboratories complete the programme.
Conclusion—SLMTA has transformed the laboratory landscape in resource-limited countries 
worldwide and has the potential to make a substantial and sustainable impact on the quality of 
laboratory testing and patient care.
Introduction
Substantial resources have been invested in management training and development to help 
scale up and improve the quality of health services in order to reach the United Nation’s 
Millennium Development Goals.1 However, evidence is scarce in terms of the impact that 
has actually been achieved. An international meeting convened by the World Health 
Organization (WHO) in 2005 on strengthening leadership and management in low-income 
countries concluded that programme evaluation often focuses on the number of trainees and 
pre-/post-knowledge-based tests; evaluation of programme impact on managers’ daily work 
and job outcomes is more the exception than the norm.2
Strengthening Laboratory Management Toward Accreditation (SLMTA) is a large-scale 
effort aimed at improving the quality of laboratory services and patient care in resource-
limited settings by developing competent laboratory managers. SLMTA provides an 
innovative training curriculum on implementing practical Quality Management Systems 
(QMS) using existing resources with built-in accountability and evaluation that focuses on 
result-oriented outcome measures.3 Launched in 2009 in Kigali, Rwanda, this programme 
seeks to engage laboratories in continuous quality improvement and to accelerate their 
preparations toward accreditation to international standards.4,5
In this article, we present evidence from the first four years of SLMTA programme 
implementation (2010–2013). We report data on changes in levels of laboratory compliance 
with International Organization for Standardization (ISO) 15189 requirements using the 
WHO Regional Office for Africa’s (WHO AFRO) accreditation preparedness checklist. The 
findings from this unprecedented study shed light on the widespread success of an 
innovative programme that has empowered laboratory teams throughout the developing 
world to strive for continuous quality improvement and work toward accreditation, despite 
limited resources.
Research methods and design
SLMTA implementation and evaluation
The methodology of the SLMTA programme has been described previously.3,5 Briefly, 
SLMTA is a competency-based programme that uses a series of short courses and work-
based learning projects to effect rapid and measurable laboratory improvement for better 
patient care through enhanced management skills and implementation of practical quality 
management systems. The SLMTA training programme is based on a series of three 
workshops. After each workshop, participants implement improvement projects supported 
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by regular supervisory visits or on-site mentoring. Laboratories are evaluated using WHO 
AFRO’s Stepwise Laboratory Quality Improvement Process Towards Accreditation 
(SLIPTA) checklist,6 which includes 111 items divided into 12 sections that represent the 12 
Quality System Essentials (QSEs).7 In order to assess progress made by the laboratories, 
audits are conducted using the SLIPTA checklist at the beginning (baseline) and at the end 
(exit) of the SLMTA programme. Many countries also conduct intermediate audits to help 
guide programme implementation, as well as surveillance audits after exiting the programme 
so as to monitor continued improvement and assess sustainability. After an audit, 
laboratories receive a score which determines their star rating – from zero to five, with < 
55% corresponding to zero stars, 55% – 64% one star, 65% – 74% two stars, 75% – 84% 
three stars, 85% – 94% four stars and ≥ 95% five stars. When a laboratory achieves a five-
star rating, it may be encouraged to seek accreditation.
Data analysis
Programme data up to December 2013 were collected from all countries implementing 
SLMTA. Variables included year of implementation, number and types of laboratories in 
each cohort (i.e., enrolment in the same training round), number of people trained, audit 
scores and approximate number of tests conducted by each laboratory. Data were collated 
and analysed in Microsoft® Excel 2013. Descriptive statistics (percentages, medians, ranges) 
were calculated. Statistical significance of improvements were assessed using 2-tailed t-tests 
for equal variances (f-tests showed equal variances at p > 0.1); comparison of improvements 
across laboratory types was assessed using one-way analysis of variance (ANOVA).
Given the wide variations in the time between the baseline audit and the first SLMTA 
workshop, programme length was defined as the time from the first SLMTA workshop to 
the exit audit. In some countries, results for large national reference laboratories were 
reported by department rather than for the laboratory as a whole. For consistency, we 
aggregated the department scores into a single score per laboratory, using median values 
across laboratory departments. We estimated the number of laboratory tests conducted in 
SLMTA laboratories based on country reports for 2012; missing data were imputed using 
averages by laboratory type.
Results
Programme spread
Since its introduction in 2009, SLMTA has been implemented in 47 countries worldwide, 
including 23 countries in Africa, 12 in the Caribbean Region, 10 in Central and South 
America, and two in Southeast Asia (Figure 1, Table 1).
As of December 2013, 65 SLMTA cohorts had been initiated, with one to 55 laboratories 
per cohort. Thirty were first cohorts within countries, including three regional cohorts which 
encompassed multiple countries, whilst the remaining 35 were subsequent cohorts in 23 
countries as they expanded the programme (Table 1).
A total of 1923 people from 617 laboratories were trained. Thirty-seven of these laboratories 
(6%) were re-enrolled in a subsequent SLMTA cohort. Eighteen per cent of the 617 
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laboratories were at the national level, 27% at regional or provincial levels, 38% at district 
or primary levels, 10% belonged to non-governmental, faith-based or private organisations, 
5% were military laboratories and 2% were blood banks. Nearly all (98%) of these 
laboratories provide HIV-related services, such as HIV diagnosis, treatment monitoring, 
opportunistic infection or tuberculosis testing, and blood bank testing. Of these laboratories, 
302 (49%) completed the SLMTA programme and conducted an exit audit, whilst the 
remaining 315 (51%) were still going through the programme at the time of this analysis.
Audit results
At the baseline audit, the mean score for all 617 SLMTA-enrolled laboratories was 39% 
(median 37%) and 84% received zero stars (i.e., score < 55%) on the SLIPTA five-star scale 
(Table 1). For the 302 laboratories that had completed the programme and conducted an exit 
audit, mean scores increased from 39% at baseline to 64% at exit (p < 0.001). Whilst 85% 
had received zero stars at baseline, only 30% remained at zero stars at exit (Figure 2).
The average improvement from baseline to exit audit was 25 percentage points over a mean 
programme duration of 16 months. Sixty-eight per cent of laboratories improved by at least 
one star, including 22% that increased by three or more stars. Although 32% of the 
laboratories did not increase their stars, 23% of these more than doubled their scores from 
baseline to exit. Improvements tended to be higher for laboratories with lower baseline 
scores. Those with a starting score below 25% had an average increase of 37 percentage 
points, whilst those with a starting score of 65% or higher had an average increase of nine 
percentage points (r = −0.49, p < 0.001) (Table 2).
Baseline and exit scores and improvements were similar between the different types of 
laboratories (p > 0.05) (Figure 3). Amongst laboratories that had completed the SLMTA 
programme, the 132 laboratories implementing SLMTA in the first year (2010) had the 
same mean improvement as the 170 laboratories implementing SLMTA in 2011 to 2013 (24 
percentage points).
Sustainability
Ninety-two laboratories had conducted post-SLMTA surveillance audits, at a median of 11 
months post-exit audit (range five to 28 months). Of these laboratories, 62% further 
increased their score, including 34% whose score increased by > 10 percentage points post-
exit audit (Figure 4). Of the national-level laboratories that conducted post-SLMTA audits 
(n = 19), 79% improved their scores, whilst only 56% of district-level laboratories (n = 27) 
further increased their scores (p = 0.03). Overall, there was regression toward the mean, as 
laboratories that received lower scores at exit were more likely to improve their scores at the 
post-SLMTA audit (r = −0.48, p < 0.001).
As of September 2014, six SLMTA laboratories have been accredited to international 
standards (Table 3). These laboratories had baseline scores approximately equal to all 
SLMTA laboratories, with a median score of 38% (range 29% to 75%) as compared to a 
median of 37% for all SLMTA laboratories; one of the laboratories started at three SLIPTA 
stars, whilst the other five laboratories began at zero stars. At the exit audit, the six 
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laboratories had a median score of 90%, with an increase of 52 percentage points, as 
compared to the international average of 64% and 25 percentage points. The median time 
from SLMTA initiation to accreditation was 31.5 months (range 17–54). In March 2013, the 
Kenya HIV National Reference Laboratory became the first SLMTA laboratory (and the 
first public medical laboratory in Kenya) to earn accreditation.8 The Hai Duong Preventive 
Medicine Center in Vietnam had the lowest baseline score of the six laboratories at 29%, but 
achieved the greatest improvement from baseline to exit (58 percentage points); it took the 
laboratory only 19 months from initiation of SLMTA to accreditation.
SLMTA implications for laboratory testing
In total, the 617 SLMTA laboratories conducted an estimated 111 million tests in 2012. 
Approximately 43.5 million of these tests were conducted by the 302 laboratories that had 
completed the SLMTA programme by the time of this analysis. Only 16% of these tests 
were conducted by laboratories with at least one quality star prior to SLMTA 
implementation (3% had ≥ 3 stars); after SLMTA training 68% of tests were performed by 
laboratories with at least one quality star (28% had ≥ 3 stars). This translates to 
approximately 23 million tests conducted by laboratories that previously had zero stars and 
now have one or more stars. Furthermore, within the group with zero stars prior to SLMTA 
implementation, more than one in three tests were performed by laboratories scoring below 
35% on the SLIPTA checklist; after SLMTA completion this proportion decreased to one in 
50 (Figure 5). Assuming similar quality improvements for the 315 currently-enrolled 
laboratories, we project the total number of tests conducted by laboratories with one or more 
stars that had previously been at zero stars to rise to 58 million by the end of 2015.
Discussion
Since its launch in 2009, SLMTA has achieved wide global coverage and demonstrated 
measurable improvement using a standardised checklist, transforming the laboratory 
landscape in many resource-limited countries worldwide. The results have been remarkable, 
with audit scores increasing 25 percentage points, and two-thirds of the laboratories that 
completed the SLMTA programme improving by at least one quality star level. Twenty-
three countries have implemented a second cohort of training and 23 million tests conducted 
by laboratories previously lacking any quality management system are now being conducted 
by laboratories with at least a basic level of quality in place. The SLMTA programme has 
the potential to make a substantial and sustainable impact on the quality of laboratory testing 
and, therefore, patient care.
As of August 2014, 102 laboratories from 15 countries in sub-Saharan Africa had received 
an official WHO AFRO SLIPTA audit by the African Society for Laboratory Medicine 
(ASLM) (Maruta T, 2014, personal communication, August 31); ninety-seven (95%) of 
these laboratories had gone through the SLMTA programme. It is evident that SLMTA has 
emerged as a vital strategy in accelerating laboratory preparedness for accreditation in the 
developing world and in facilitating the fulfillment of ASLM’s 2020 Vision, Goal 2: ‘by 
2020, enroll 2500 laboratories in the WHO SLIPTA quality improvement programme and 
enable 250 laboratories to achieve accreditation by international standards’.9
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To date, the SLMTA programme has been primarily funded by the US President’s 
Emergency Plan for AIDS Relief (PEPFAR) through CDC and implementation has been 
limited primarily to PEPFAR-supported countries. Although HIV-focused, these resources 
have been leveraged to build wide-spread capacity and strengthen the overall laboratory 
system.10 Slowly, partners are joining ranks to help spread the programme. Since 2011, the 
World Bank has funded five countries (Burundi, Kenya, Rwanda, Tanzania and Uganda) to 
implement SLMTA in 32 laboratories through its East Africa Public Health Laboratory 
Network Project. The Southern African Development Community (SADC) will soon partner 
with the Zimbabwe National Quality Assurance Program in spreading the programme to all 
15 member states, some of which are not supported by PEPFAR.
This is the first study to examine the existing level of laboratory quality on a broad 
international scale. The mean baseline audit score of the 617 SLMTA-enrolled laboratories 
was 39%, well below the 55% required to attain even the lowest quality level on the 
SLIPTA scale, and only 16% of the laboratories met or surpassed the one-star level. These 
results paint a bleak picture of the current quality of laboratories in much of the developing 
world. Whilst the issue of the lack of quality amongst laboratories in developing countries 
has been acknowledged in numerous publications4,11,12,13,14,15,16,17 and a series of policy 
statements,18,19,20,21 the current study begins to quantify the problem and sheds some light 
on a potential solution.
The SLMTA curriculum was designed to be closely aligned to ISO 15189; however, it has 
proven to be suitable to support other standards as well. For example, a SLMTA-enrolled 
laboratory in Vietnam that tests environmental and food samples was accredited to ISO 
17025. Two per cent of SLMTA sites are blood banks or blood-transfusion centres, which 
use different standards and have their own accreditation programmes. In Cameroon, inspired 
by the transformation achieved by its SLMTA-enrolled laboratory, a hospital adopted 
SLMTA in order to embark on its own quality improvement journey.22 The need for 
improved quality is so widespread that others have called for the expansion of SLMTA into 
a programme that helps guide quality improvement in entire hospital and public health 
systems.23
According to a May 2013 survey, only two government-owned medical laboratories in the 
48 sub-Saharan African countries outside of South Africa were accredited.11 In 2013 to 
2014, three more government-owned laboratories in the region (all located in Kenya) were 
accredited after SLMTA implementation (Table 3). In the same timeframe, two SLMTA 
laboratories outside of the sub-Saharan region have achieved accreditation, whilst several 
others are awaiting accreditation assessments. These are only the first of what we anticipate 
will be many SLMTA laboratories reaching accreditation as the programme matures, since 
preparing for accreditation is a multi-year process. However, it is not feasible, either 
economically or programmatically, for all laboratories to pursue accreditation to 
international standards. As countries develop laboratory strategic plans, they will need to 
assess the options and develop realistic goals. The Ministry of Health in Uganda, for 
example, has set a national target of three stars for general hospital laboratories and five 
stars for national and regional reference laboratories (Lali W, 2014, personal 
communication, August 31). Regardless of the ultimate goal, the SLMTA programme will 
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provide the tools necessary to guide laboratories in the continuous quality improvement 
process designed to achieve better patient care.
It is outside the scope of this study to examine how factors such as cohort size, programme 
length, laboratory type, mentorship model (amount, quality and type) and additional training 
impact the performance of the programme. However, detailed data are being collected as 
part of the SLMTA programme, including audit scores for each of the 12 QSEs and 
laboratory indicators such as turnaround time, specimen rejection rates, equipment 
downtime, proficiency testing, customer satisfaction and cost. These data are a potential 
gold mine of information that could be harnessed to identify causative factors of success and 
to fine-tune the programme with evidence-based strategies for continued improvement. An 
electronic-tool that will facilitate collection, management, aggregation, analysis and 
reporting of SLMTA programmatic data on a global level is currently under development by 
CDC and its partners.
Limitations of the study
These study results should be interpreted in light of several limitations. Firstly, half of the 
enrolled laboratories have not yet completed the programme and therefore have no exit audit 
data. As the programme matures, a higher proportion of the participating laboratories will 
have full data, reducing the risk of bias. Similarly, whilst we found that most laboratories 
that conducted surveillance audits continued to improve over a time-span of anywhere from 
five to 28 months after the SLMTA programme ended, the programme is too young to 
assess long-term sustainability. Another concern is the quality of the audits, especially in the 
initial years of the SLMTA programme before formal training and certification of auditors. 
Whilst the SLIPTA checklist was designed to help standardise audit scoring, some 
variability may remain; assessment of intra- and inter-auditor variability is needed.
This was an observational programmatic study. Many factors were not controlled, such as 
programme duration, size of cohorts, mentorship model and additional training provided to 
enrolled laboratories. Future studies that compare these factors, as well as results of SLMTA 
laboratories with non-SLMTA laboratories are needed in order to separate the impact of 
SLMTA implementation from natural improvement in laboratory quality over the duration 
of the programme. In addition, estimates of the number of laboratory tests were based on 
353 (57%) laboratories that submitted information; missing data were imputed using average 
volume by laboratory type, but some uncertainty remains.
Ultimately, a thorough evaluation of the SLMTA programme will require assessment of 
programme impact on patient care and health outcomes. Systematic evaluation of key 
indicators is needed, as well as targeted evaluations of programme cost-benefit, the impact 
of quality improvement on testing error rates and the association of quality services with 
patient outcomes, so as to determine public and personal health implications.
Conclusion
Few management and leadership development programmes have been implemented on such 
a large scale with results-oriented outcome measures. With data collected from 617 
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laboratories in 47 countries throughout Africa, the Caribbean, Latin America and Southeast 
Asia, SLMTA is truly a global effort. It has demonstrated its ability to transform the 
laboratory landscape in resource-limited countries worldwide. Evidence from this study 
suggests that the SLMTA programme has the potential to make a substantial and sustainable 
impact on the quality of laboratory testing and patient care.
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Country Author #1 Name Author #2 Name Grant no.
Angola Margarida Rodrigues Filomena Gomes da 
Silva
AFENET 5U2GPS002728
Botswana Kelebeletse Mokobela Mpho Moatshe GH000073
Burundi Stanislas Nyandwi Jean Marie Vianney 
Ngendakabaniga
East African Public Health 
Laboratory Networking Project
Cambodia Chuop Sokheng Uch Monipheap PS000939
Cameroon Judith D. Shang Laura Takang Eno 3U2GPS002739-03S1
Caribbean George Alemnji Giselle Guevara (AFENET)PS10-10119
Central America Region Sandra Juarez Ana Malla de Abreu 5U19GH00064
Cote d’Ivoire Christiane Adje Toure Ramatou Toure Hamidou ASCP U2GPS001285-06
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Country Author #1 Name Author #2 Name Grant no.
Dominican Rep Ana Malla de Abreu Rosa Hazim FIND: U2GPS002746-03
D.R. Congo Abiola Nadine Kabwe Constantin U2G PS001799 (APHL)





Ghana Veronica Bekoe Beatrice van der Puije PS10-1070 U2GPS002762
5U2GPS002987
Haiti Josiane Buteau Mary Nagel U2GPS001285-06
Kenya Ernest Makokha Jane Mwangi ASCP: Grant # PS001285
AGHPF: Grant # PS001865
AFENET: Grant # PS002728
Lesotho Mary Sekautu Mathabo Lebina CoAg# PS002076
Malawi Elde Paladar Henry Limula 3U2GPS001938-04
Mozambique Eduardo Samogudo Antonio Assane ASCP- 5U2GPS001285-01
INS – 1U2GGH000080-01
APHL- U2G/PS001799-03
Namibia Mary Mataranyika Souleymane Sawadogo MoHSS - CDC-RFA- PS10- 1095





Rwanda Jean Marie Vianney 
Ngendakabaniga
Alida Ngwije U2GPS000642
Sierra Leone Isatta Wurie Fay Rhodes APHL U2GPS001799
South Africa Patience Dabula Zawadi Chipeta U2GPS001328-05
South Sudan Lucy A. Mambo Hakim Idris U2GPS001799
Swaziland Samson Haumba Makhosanana Shabalala 3U2GPS001896
Tanzania Dickson Majige Abdul Mwanja 5U2GPS001788
Uganda William Lali Kamaranzi Bakunda PS002724: CDC-RFA-PS10-102603





Zambia Fales Zulu Mwamba Davy Nsama MOH CoAg Grant # U2GPS001792
APHL CoAg Grant # U2GPS001799
ASM CoAg Grant # U2GPS001947
Zimbabwe Sibongile Zimuto Phoebe Nzombe 3U2GPS003124
Organisation
CDC-Atlanta John Nkengasong Luciana Kohatsu -
Mayo Clinic Barbara McKinney - -
American Society for 
Clinical Pathology 
(ASCP)
Anna Murphy Mary (Kitty) Linde -
African Society for 
Laboratory Medicine 
(ASLM)
Talkmore Maruta Nqobile Ndlovu -
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Sikhulile Moyo - -
East, Central and 
Southern African Health 
Community (ECSA-
HC)
Martin Matu - -
Naval Medical Research 
Unit 6 (NAMRU-6)
Silvia Montano Drake H. Tilley Work Unit Number 60150
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Global reach of SLMTA by year of implementation, 2010–2013 (n = 47 countries).
SLMTA, Strengthening Laboratory Management Toward Accreditation.
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Star levels at baseline and exit amongst the 302 laboratories completing the Strengthening 
Laboratory Management Toward Accreditation programme, 2010–2013. Results based on 
the Stepwise Laboratory Quality Improvement Process Towards Accreditation checklist 
baseline and exit audit scores.
Note: Each square represents one laboratory.
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Baseline and exit scores by laboratory type for the 302 laboratories completing the 
Strengthening Laboratory Management Toward Accreditation programme 2010–2013 based 
on the Stepwise Laboratory Quality Improvement Process Towards Accreditation checklist.
NGO, non-governmental organisation.
Yao et al. Page 14














Post-SLMTA surveillance audits (n = 92 laboratories), based on the Stepwise Laboratory 
Quality Improvement Process Towards Accreditation checklist.
SLMTA, Laboratory Management Toward Strengthening Accreditation.
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Estimated proportion of 43.5 million tests performed by star level of laboratories before (a) 
and after (b) SLMTA implementation, based on the Stepwise Laboratory Quality 
Improvement Process Towards Accreditation checklist scores for the 302 laboratories that 
completed the SLMTA programme. Before SLMTA: 16% of tests were done in laboratories 
with at least one star. After SLMTA 68% of tests were done in laboratories with at least one 
star.
SLMTA, Strengthening Laboratory Management Toward Accreditation.
Yao et al. Page 16
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TABLE 2
Improvement by baseline level based on the Stepwise Laboratory Quality Improvement Process Towards 
Accreditation checklist.
Baseline level n Mean baseline audit score (%) Mean exit audit score (%) Mean change (percentage points)
0% – 24% 59 19 56 37
25% – 34% 66 30 56 26
35% – 44% 73 39 62 23
45% – 54% 59 48 68 20
55% – 64% 23 59 79 20
65% + 22 75 84 9
Total 302 39 64 25
NGO, non-governmental organisation.
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